Insider Profile
Johnson, Neil Allan
$MRVL $TTI
2
Companies Filed At
1
Open-Market Buys (2yr)
$6K
Buy Value (2yr, open-market)
May 19, 2026
Most Recent Trade
Date Company Role Nature Dir. Shares Price Value Score
May 19, 2026 $MRVL
Marvel Biosciences Corp.
— Other Buy 16,667 $0.15 $3K 33
Feb 17, 2026 $MRVL
Marvel Biosciences Corp.
— Other Buy 16,667 $0.15 $3K 33
Oct 31, 2025 $MRVL
Marvel Biosciences Corp.
— Other Buy 11,899 $0.21 $2K 33
Aug 16, 2024 $MRVL
Marvel Biosciences Corp.
— Open Market Buy 50,000 $0.11 $6K 33
Jul 23, 2024 $MRVL
Marvel Biosciences Corp.
— Comp. Grant Buy 125,000 — — 33
Sep 26, 2022 $MRVL
Marvel Biosciences Corp.
— Comp. Grant Buy 200,000 $0.10 $20K 33
Jul 18, 2022 $MRVL
Marvel Biosciences Corp.
— Open Market Sell 250,000 $0.10 $25K 33
Mar 22, 2022 $TTI
Thiogenesis Therapeutics, Corp.
— Exercise Buy 125,000 $0.10 $12K —
Mar 22, 2022 $TTI
Thiogenesis Therapeutics, Corp.
— Exercise Sell 125,000 $0.10 $12K —
Mar 18, 2022 $MRVL
Marvel Biosciences Corp.
— Open Market Buy 30,000 $0.14 $4K 33
Jun 14, 2021 $MRVL
Marvel Biosciences Corp.
— Other Sell — — — 33
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.